High frequency repetitive transcranial magnetic stimulation versus sertraline in treatment of poststroke depression: A pilot study

Authors

  • Pim Terachinda Chulalongkorn University, Bangkok, Thailand
  • Anuphan Tantanatip Chulalongkorn University, Bangkok, Thailand
  • Krisna Piravej Chulalongkorn University, Bangkok, Thailand
  • Sookjareon Tangwongchai Chulalongkorn University, Bangkok, Thailand
  • Sunisa Srioum Thai Red Cross Rehabilitation Center, Thai Red Cross Society, Samut Prakarn, Thailand
  • Thipwimon Sillapachai Thai Red Cross Rehabilitation Center, Thai Red Cross Society, Samut Prakarn, Thailand
  • Pisamai Hongsachat Thai Red Cross Rehabilitation Center, Thai Red Cross Society, Samut Prakarn, Thailand
  • Yuda Chongpison Center of Excellence in Biostatistics, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Keywords:

Stroke, depression, repetitive transcranial magnetic stimulation, sertraline

Abstract

Background: Poststroke depression (PSD) has impact on rehabilitation outcome. Repetitive transcranial magnetic stimulation (rTMS) has been proven as a treatment of depression and might reduce depressive symptoms after stroke.

Objectives: To determine the effects of high frequency rTMS in treatment of PSD compared to sertraline. We also investigated the effects of rTMS combined with sertraline.

Methods: Fourteen patients with PSD were randomly allocated into 3 groups: 1) the rTMS group received 10 sessions of 10 Hz rTMS; 2) the sertraline group obtained sertraline 50 mg daily and sham rTMS; and, 3) the combined group received 10 Hz rTMS combined with sertraline 50 mg daily. Hamilton rating scale for depression (HAM-D) was assessed at baseline and week 2, 6 and 14. At baseline and week 6 and 14, modified Barthel Index (MBI) and Brunnstrom stages of stroke recovery were evaluated.

Results: The rTMS group showed significant reduction of HAM-D score at week 6 (- 9.8 gif.latex?\pm 7.1; P < 0.05) while the sertraline and combined groups did not show significant improvement (- 9.2 gif.latex?\pm 1.0 and - 4.8 gif.latex?\pm 2.9, respectively). HAM-D, response and remission rate, response and remission over the time, MBI and motor recovery among groups were not significantly different.

Conclusion: High frequency rTMS might have antidepressant effect in PSD. Its effect might not be different from sertraline. Benefit of rTMS given in combination with sertraline over rTMS or sertraline alone is still inconclusive.

Downloads

Download data is not yet available.

References

Ayerbe L, Ayis S, Wolfe CD, Rudd AG. Natural history, predictors and outcomes of depression after stroke: Systematic review and meta-analysis. Br J Psychiatry 2013;202:14-21.

https://doi.org/10.1192/bjp.bp.111.107664

Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and metaanalysis of observational studies. Int J Stroke 2014;9:1017-25.

https://doi.org/10.1111/ijs.12357

Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP. The sunnybrook stroke study: a prospective study of depressive symptoms and functional outcome. Stroke 1998;29:618-24.

https://doi.org/10.1161/01.STR.29.3.618

Kotila M, Numminen H, Waltimo O, Kaste M. Poststroke depression and functional recovery in population-based stroke register. The Finnstroke study. Eur J Neurol 1999;6:309-12.

https://doi.org/10.1046/j.1468-1331.1999.630309.x

Kauhanen M, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999;30:1875-80.

https://doi.org/10.1161/01.STR.30.9.1875

Pohjasvaara T, Vataja R, Leppävuori A, Kaste M, Erkinjuntti T. Depression is an independent predictor of poor long-term functional outcome post-stroke. Eur J Neurol 2001;8:315-9.

https://doi.org/10.1046/j.1468-1331.2001.00182.x

Karaahmet OZ, Gurcay E, Avluk OC, Umay EK, Gundogdu I, Ecerkale O, et al. Poststroke depression: Risk factors and potential effects on functional recovery. Int J Rehabil Res 2017;40:71-5.

https://doi.org/10.1097/MRR.0000000000000210

Bhattacharjee S, Al Yami M, Kurdi S, Axon DR. Prevalence, patterns and predictors of depression treatment among community-dwelling older adults with stroke in the United States: a cross sectional study. BMC Psychiatry 2018;18:130. https://doi.org/10.1186/s12888-018-1723-x

Sun Y, Liang Y, Jiao Y, Lin J, Qu H, Xu J, et al. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: A multiple-treatments meta-analysis. BMJ Open 2017;7:e016499.

https://doi.org/10.1136/bmjopen-2017-016499

Li X, Zhang C. Comparative efficacy of nine antidepressants in treating Chinese patients wit post-stroke depression: A network meta-analysis. J Affect Disord 2020;266:540-8.

https://doi.org/10.1016/j.jad.2020.02.005

Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG, et al. Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 2009;169: 2128-39.

https://doi.org/10.1001/archinternmed.2009.436

Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: A review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry 2010;71:1565-75. https://doi.org/10.4088/JCP.09r05786blu

Barker AT. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol 1991;8:26-37. https://doi.org/10.1097/00004691-199101000-00005

Valero-Cabré A, Amengual JL, Stengel C, PascualLeone A, Coubard OA. Transcranial magnetic stimulation in basic and clinical neuroscience: a comprehensive review of fundamental principles and novel insights. Neurosci Biobehav Rev 2017;83:381-404. https://doi.org/10.1016/j.neubiorev.2017.10.006

Lefaucheur JP, Aleman A, Baeken C, Benninger DH, Brunelin J, Di Lazzaro V, et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). Clin Neurophysiol 2020;131:474-528. https://doi.org/10.1016/j.clinph.2019.11.002

Jorge RE, Robinson RG, Tateno A, Narushima K, Acion L, Moser D, et al. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry 2004;55:398-405. https://doi.org/10.1016/j.biopsych.2003.08.017

Jorge RE, Moser DJ, Acion L, Robinson RG. Treatment of vascular depression using transcranial magnetic stimulation. Arch Gen Psychiatry 2008;65:268-76.

https://doi.org/10.1001/archgenpsychiatry.2007.45

Gu SY, Chang MC. The effects of 10-Hz repetitive transcranial magnetic stimulation on depression in chronic stroke patients. Brain Stimul 2017;10:270-4. https://doi.org/10.1016/j.brs.2016.10.010

Lotrakul M, Sukanich P, Sukying P. The reliability and validity of Thai version of Hamilton Rating Scale for depression. J Psychiatr Assoc Thai 1996;41:235-46.

Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, et al. Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology 2006;31:1841-53.

https://doi.org/10.1038/sj.npp.1301131

Moller HJ. Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment. World J Biol Psychiatry 2008;9:102-14.

https://doi.org/10.1080/15622970801981606

Loharjun B, Wannapira P, Palivanit J, Cumjun K. Reliability of modified Barthel Index (Thai version) assessment in stroke patients. Buddhachinaraj Med J 2008;25:842-51.

Brunnstrom S. Motor testing procedures in hemiplegia: based on sequential recovery stages. Phys Ther 1966;46:357-75. https://doi.org/10.1093/ptj/46.4.357

Fabre LF, Abuzzahab FS, Amin M, Claghorn JL, Mendels J, Petrie WM, et al. Sertraline safety and efficacy in major depression: a double-blind fixeddose comparison with placebo. Biol Psychiatry 1995; 38:592-602. https://doi.org/10.1016/0006-3223(95)00178-8

Hieronymus F, Nilsson S, Eriksson E. A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors. Transl Psychiatry 2016;6:e834. https://doi.org/10.1038/tp.2016.104

Shen X, Liu M, Cheng Y, Jia C, Pan X, Gou Q, et al. Repetitive transcranial magnetic stimulation for the treatment of post-stroke depression: a systematic review and meta-analysis of randomized controlled clinical trials. J Affect Disord 2017;211:65-74. https://doi.org/10.1016/j.jad.2016.12.058

Liu C, Wang M, Liang X, Xue J, Zhang G. Efficacy and safety of high-frequency repetitive transcranial magnetic stimulation for poststroke depression: a systematic review and meta-analysis. Arch Phys Med Rehabil 2019;100:1964-75. https://doi.org/10.1016/j.apmr.2019.03.012

Downloads

Published

2023-10-17

How to Cite

1.
Terachinda P, Tantanatip A, Piravej K, Tangwongchai S, Srioum S, Sillapachai T, Hongsachat P, Chongpison Y. High frequency repetitive transcranial magnetic stimulation versus sertraline in treatment of poststroke depression: A pilot study. Chula Med J [Internet]. 2023 Oct. 17 [cited 2024 Nov. 22];65(1). Available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/1077

Issue

Vol. 65 No. 1 (2021): Chulalongkorn Medical Journal

Section

Other

License

Copyright (c) 2023 Chulalongkorn Medical Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Similar Articles

You may also start an advanced similarity search for this article.